Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors

BACKGROUND: Natural killer (NK) cells are increasingly being recognized as agents for cancer immunotherapy. The killer cell immunoglobulin-like receptors (KIRs) are expressed by NK cells and are immunogenetic determinants of the outcome of cancer. In particular, KIR2DS2 is associated with protective...

Descripción completa

Detalles Bibliográficos
Autores principales: Rettman, Pauline, Blunt, Matthew D, Fulton, Rebecca J, Vallejo, Andres F, Bastidas-Legarda, Leidy Y, España-Serrano, Laura, Polak, Marta E, Al-Shamkhani, Aymen, Retiere, Christelle, Khakoo, Salim I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141441/
https://www.ncbi.nlm.nih.gov/pubmed/34016721
http://dx.doi.org/10.1136/jitc-2020-001912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141441/
https://www.ncbi.nlm.nih.gov/pubmed/34016721
http://dx.doi.org/10.1136/jitc-2020-001912

Ejemplares similares